The further refinement of ROP treatment. commentary on the early treatment of retinopathy of prematurity study: structural findings at 2 years of age

Editorial

Alistair R Fielder et al. Br J Ophthalmol. 2007 Feb.

. 2007 Feb;91(2):136-7.

doi: 10.1136/bjo.2006.107813.

Abstract

Reaching the goal of early ROP treatment by recent advances in ROP management

Competing interests: None declared.

The Early Treatment for Retinopathy of Prematurity Clinical Trial: presentation by subgroups versus analysis within subgroups.
Hardy RJ, Good WV, Dobson V, Palmer EA, Tung B, Phelps DL, Shapiro MJ, van Heuven WA. Hardy RJ, et al. Br J Ophthalmol. 2006 Nov;90(11):1341-2. doi: 10.1136/bjo.2006.102038. Br J Ophthalmol. 2006. PMID: 17057172 Free PMC article.

1. Early Treatment for Retinopathy of Prematurity Cooperative Group The Early Treatment of Retinopathy Of Prematurity Study : structural findings at 2 years of age. Br J Ophthalmol 2006901341–1342. - PMC - PubMed
1. Early Treatment for Retinopathy of Prematurity Cooperative Group Revised indications for the treatment of retinopathy of prematurity. Arch Ophthalmol 20031211684–1696. - PubMed
1. Averbukh E. The evidence supporting the early treatment for type 1 retinopathy of prematurity needs further evaluation. Arch Ophthalmol 2005123406 - PubMed
1. Vander J F, McNamara J A, Tasman W.et al Revised indications for early treatment of retinopathy of prematurity. Arch Ophthalmol 2005123406–407. - PubMed
1. Jalali S, Essuman V A, Thomas R. Clinical application of the revised indications for the treatment of retinopathy of prematurity. Arch Ophthalmol 2005123407–408. - PubMed